Trikafta (elexacaftor/ivacaftor/tezacaftor)

Vertex
Pharma

Vertex's Trikafta at center of new pricing controversy

Lacking access to Vertex's Trikafta, cystic fibrosis patients and activists in four countries are attempting to take matters into their own hands.
Fraiser Kansteiner Feb 7, 2023 10:59am
Vertex

Don't pigeonhole Vertex as a rare disease company, execs say

May 6, 2022 7:55am